Polymyositis Archives

Incidence, Prevalence, and Mortality of Dermatomyositis in Adults Determined

By

Inga Back, MPH

November 18, 2021

Using the ACR/EULAR criteria, researchers studied the population-based incidence, prevalence, and mortality of dermatomyositis in adults.

Inflammatory Myopathy

Novel GLP-1 Receptor Agonist Designated Orphan Drug for Polymyositis

By

Brian Park, PharmD

October 1, 2021

The FDA has granted Orphan Drug designation to PF1801 for the treatment of polymyositis.

Inflammatory Myopathy

Evidence Supports Content Validity of Patient-Reported Outcome Measures in Inflammatory Myositis

By

Amit Akirov, MD

October 15, 2020

Researchers investigated the content validity of patient-reported outcome measures in patients with idiopathic inflammatory myopathies.

Pediatric Rheumatology

Case Report: Anti-Ku Antibodies Identified in Systemic Sclerosis-Polymyositis Overlap Syndrome in an Adolescent

By

Morgan E. Meissner

July 21, 2020

Authors of a report presented the case of systemic sclerosis-polymyositis overlap syndrome in an adolescent with anti-Ku antibodies.

Myositis

Predictors Identified for Myositis-Related Interstitial Lung Disease Mortality

By

Liam Berry

April 12, 2018

Researchers identified independent predictors of short-term dermatomyositis- or polymyositis-related interstitial lung disease mortality.

Myositis

Tacrolimus Decreases Glucocorticoid Use in Refractory Myositis-Associated Interstitial Lung Disease

By

Sheila Jacobs

September 27, 2017

Factors associated with favorable treatment responses to conventional therapy and tacrolimus in myositis-associated interstitial lung disease were examined in a retrospective cohort study.

Myositis

Polymyositis May Increase Risk of Amyotrophic Lateral Sclerosis

By

Laura Stiles

October 14, 2016

The relationship between PM and ALS could indicate a common pathophysiology.

Myositis

Increased Incidence of LV Diastolic Dysfunction in PM/DM

By

Corinna Sison, MD

July 19, 2016

Patients with PM or DM had an increased prevalence of cardiac abnormalities, most commonly left ventricular diastolic dysfunction, compared with healthy controls.

Inflammatory Myopathy

Exercise May Reduce Impairment in Inflammatory Myopathies

February 20, 2016

Five randomized controlled trials including adult patients with polymyositis and dermatomyositis (DM) and additional open studies have demonstrated reduced impairment and activity limitation as well as improved quality of life. Exercise can improve muscle aerobic capacity as shown by increased mitochondrial enzyme activity. These data suggest that intensive aerobic exercise and resistance training could reduce disease activity and inflammation and improve muscle metabolism.